文献速递心律失常

阵发性房颤触发因素个体化研究:I-STOP-AFib随机临床试验

Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation: The I-STOP-AFib Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2022-01-01

该随机临床试验在446例有症状的阵发性房颤患者中,使用智能手机应用进行n-of-1触发因素测试,主要终点为10周时AFEQT评分。结果显示n-of-1测试未显著改善房颤相关生活质量,但与对照组相比,干预后4周内每日房颤发作显著减少(调整相对风险0.60)。个体化试验的荟萃分析中,仅酒精暴露与房颤事件风险显著升高相关。

要点

  • n-of-1触发因素测试未改善阵发性房颤患者的生活质量评分。
  • 触发测试后4周内房颤发作较对照组显著减少。
  • 仅酒精暴露与房颤事件风险升高相关,咖啡因等未显示触发证据。

核心结论

  • n-of-1房颤触发因素测试未改善房颤相关生活质量,但与房颤事件减少相关。
  • 急性酒精暴露增加房颤风险,其他暴露(包括咖啡因)未显示更常触发房颤。

研究设计与样本

  • 随机临床试验,纳入446例有症状的阵发性房颤患者,平均年龄58岁,58%为男性,92%为白人。
  • n-of-1组在6周内以随机1周区块暴露或避免自选触发因素,并告知其触发因素影响房颤风险的概率;对照组仅监测房颤。
  • 主要终点为10周时房颤对生活质量影响(AFEQT)评分,房颤通过每日自我报告和智能手机心电图设备评估。

主要发现

  • n-of-1组与仅监测组之间AFEQT评分无显著差异。
  • 干预后4周随访期内,触发测试组报告的每日房颤发作显著少于同期对照组(调整相对风险0.60;95%CI 0.43-0.83;P<.001)。
  • 个体化试验的荟萃分析中,仅酒精暴露与房颤事件风险显著升高相关。

关键数值与推荐

  • 自选触发因素包括咖啡因(n=53)、酒精(n=43)、睡眠减少(n=31)、运动(n=30)、左侧卧位(n=17)、脱水(n=10)、大量进食(n=7)、冷食或冷饮(n=5)、特定饮食(n=6)及其他定制触发因素(n=4)。

临床怎么用

  • 对于阵发性房颤患者,可考虑通过n-of-1方法测试个体触发因素以减少房颤发作,但不应期望改善生活质量。
  • 应建议患者避免急性酒精暴露以降低房颤风险。

局限性

  • 446例参与者中仅320例(72%)完成所有研究活动。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Atrial fibrillation (AF) is the most common arrhythmia. Although patients have reported that various exposures determine when and if an AF event will occur, a prospective evaluation of patient-selected triggers has not been conducted, and the utility of characterizing presumed AF-related triggers for individual patients remains unknown. OBJECTIVE: To test the hypothesis that n-of-1 trials of self-selected AF triggers would enhance AF-related quality of life. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial lasting a minimum of 10 weeks tested a smartphone mobile application used by symptomatic patients with paroxysmal AF who owned a smartphone and were interested in testing a presumed AF trigger. Participants were screened between December 22, 2018, and March 29, 2020. INTERVENTIONS: n-of-1 Participants received instructions to expose or avoid self-selected triggers in random 1-week blocks for 6 weeks, and the probability their trigger influenced AF risk was then communicated. Controls monitored their AF over the same time period. MAIN OUTCOMES AND MEASURES: AF was assessed daily by self-report and using a smartphone-based electrocardiogram recording device. The primary outcome comparing n-of-1 and control groups was the Atrial Fibrillation Effect on Quality-of-Life (AFEQT) score at 10 weeks. All participants could subsequently opt for additional trigger testing. RESULTS: Of 446 participants who initiated (mean [SD] age, 58 [14] years; 289 men [58%]; 461 White [92%]), 320 (72%) completed all study activities. Self-selected triggers included caffeine (n = 53), alcohol (n = 43), reduced sleep (n = 31), exercise (n = 30), lying on left side (n = 17), dehydration (n = 10), large meals (n = 7), cold food or drink (n = 5), specific diets (n = 6), and other customized triggers (n = 4). No significant differences in AFEQT scores were observed between the n-of-1 vs AF monitoring-only groups. In the 4-week postintervention follow-up period, significantly fewer daily AF episodes were reported after trigger testing compared with controls over the same time period (adjusted relative risk, 0.60; 95% CI, 0.43- 0.83; P < .001). In a meta-analysis of the individualized trials, only exposure to alcohol was associated with significantly heightened risks of AF events. CONCLUSIONS AND RELEVANCE: n-of-1 Testing of AF triggers did not improve AF-associated quality of life but was associated with a reduction in AF events. Acute exposure to alcohol increased AF risk, with no evidence that other exposures, including caffeine, more commonly triggered AF. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03323099.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Marcus GM, Modrow MF, Schmid CH, et al. Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation: The I-STOP-AFib Randomized Clinical Trial. JAMA Cardiol. 2022. PMID: 34775507. doi:10.1001/jamacardio.2021.5010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。